Rapid Clinical Remission With Upadacitinib in a Pediatric Patient With Refractory Crohn's Disease.
Sign Up to like & getrecommendations! Published in 2023 at "Inflammatory bowel diseases"
DOI: 10.1093/ibd/izad048
Abstract: A pediatric patient with Crohn’s disease refractory to anti-tumor necrosis factor therapy, vedolizumab, ustekinumab, and 6-mercaptopurine achieved rapid clinical remission with upadacitinib. This is the first report of successful use of upadacitinib in pediatric inflammatory… read more here.
Keywords: clinical remission; disease; crohn disease; pediatric patient ... See more keywords